Antinuclear antibody 1:100 refers to low-titer positivity of antinuclear antibody, and cytoplasmic type is the immunofluorescence karyotype classification of this patient, which suggests that the patient needs to further improve other auxiliary tests to exclude systemic lupus erythematosus, dry syndrome and other diseases.
Antinuclear antibody is an autoantibody closely associated with autoimmune diseases such as systemic lupus erythematosus and dry syndrome. Antinuclear antibody 1:100 is a low-titer positive, which can be seen in some normal people, while cytoplasmic is the immunofluorescence karyotype classification of the patient’s antinuclear antibody.
Patients with antinuclear antibody 1:100, cytoplasmic type need to further improve the blood sedimentation, rheumatoid factor, CRP, autoantibody testing and other auxiliary tests to exclude SLE, rheumatoid arthritis, dry syndrome and other diseases.
Laboratory results should be interpreted by a professional physician, and it is recommended that patients with antinuclear antibody 1:100, cytoplasmic type should go to the Department of Rheumatology and Immunology of a regular hospital for detailed consultation.